Commerce Bank bought a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 3,863 shares of the insurance provider's stock, valued at approximately $1,534,000.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Montag A & Associates Inc. increased its position in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider's stock valued at $25,000 after acquiring an additional 94 shares during the last quarter. Johnson Financial Group Inc. bought a new stake in shares of Humana in the 2nd quarter worth about $26,000. Fideuram Asset Management Ireland dac bought a new stake in shares of Humana in the 4th quarter worth about $27,000. Trust Co. of Vermont purchased a new position in shares of Humana during the 2nd quarter worth about $28,000. Finally, Reflection Asset Management bought a new position in Humana during the 4th quarter valued at about $29,000. Hedge funds and other institutional investors own 92.38% of the company's stock.
Humana Stock Performance
HUM opened at $388.92 on Wednesday. The firm has a 50 day moving average of $383.88 and a two-hundred day moving average of $285.00. The firm has a market capitalization of $46.70 billion, a PE ratio of 36.79, a P/E/G ratio of 2.20 and a beta of 0.72. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62.
Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping analysts' consensus estimates of $7.27 by $0.34. The firm had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company's revenue was up 26.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.27 earnings per share. On average, analysts anticipate that Humana Inc. will post 9.12 EPS for the current year.
Analyst Ratings Changes
A number of analysts recently weighed in on HUM shares. Guggenheim increased their price objective on shares of Humana from $269.00 to $471.00 and gave the stock a "buy" rating in a research report on Thursday, July 30th. Evercore raised shares of Humana from an "in-line" rating to an "outperform" rating and set a $480.00 price objective for the company in a research note on Wednesday, July 29th. Piper Sandler raised Humana from a "hold" rating to an "overweight" rating and set a $463.00 price target for the company in a research report on Thursday, July 30th. Sanford C. Bernstein reissued an "outperform" rating and issued a $425.00 price objective on shares of Humana in a research report on Wednesday, June 3rd. Finally, Morgan Stanley raised Humana from an "underweight" rating to an "equal weight" rating and upped their target price for the company from $249.00 to $370.00 in a research report on Tuesday, August 4th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $403.91.
Check Out Our Latest Stock Report on Humana
Humana Profile
(
Free Report)
Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Read More
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
